Orphit

Become the referent of this startup

Orphit develops clinical stage therapeutic solutions to treat neurodegenerative diseases. It lead program YMALZEN is a peptide which combines anti-inflammatory and neuroprotective properties, as a treatment for Alzheimer’s disease.
Automatic translation

Technologies

  • DEEPTECH
  • CHEMTECH

Activity area

  • HEALTHTECH
  • PHARMATECH
  • CLINIC
  • NEUROTECH
  • BIOTECH

Maturity stage

  • Early bird

http://www.orphitpharma.com/

Key information

Year of creation

2015

Workforce

< 10

Maturity stage

Early bird

Similar start-ups